Net Income Summary of BioPharma Credit PLC

BioPharma Credit PLC's latest annual net income in 2023 was 108.45 Million USD , down -40.51% from previous year.
BioPharma Credit PLC's latest quarterly net income in 2024 Q2 was 35.91 Million USD , down 0.0% from previous quarter.
BioPharma Credit PLC reported an annual net income of 182.31 Million USD in 2022, up 114.59% from previous year.
BioPharma Credit PLC reported an annual net income of 84.95 Million USD in 2021, down -4.69% from previous year.
BioPharma Credit PLC reported a quarterly net income of 35.91 Million USD for 2024 Q2, down 0.0% from previous quarter.
BioPharma Credit PLC reported a quarterly net income of 18.76 Million USD for 2023 Q4, down 0.0% from previous quarter.

Annual Net Income Chart of BioPharma Credit PLC (2023 - 2017)

Name	Net Income	Net Income Difference
Ameriprise Financial, Inc.	2.55 Billion USD	95.757%
Gladstone Investment Corporation	85.3 Million USD	-27.132%
Principal Financial Group, Inc.	623.2 Million USD	82.598%
Africa Opportunity Fund Limited	-1.68 Million USD	6519.91%
BH Macro Limited	66.49 Million USD	-63.097%
CATCo Reinsurance Opportunities Fund Ltd.	5.44 Million USD	-1893.249%
Craven House Capital Plc	-5.51 Million USD	2066.455%
JPEL Private Equity Limited	-4.75 Million USD	2383.158%
Pershing Square Holdings, Ltd.	2.48 Billion USD	95.638%
Ecofin U.S. Renewables Infrastructure Trust PLC	-6.72 Million USD	1711.92%
RTW Venture Fund Limited	83.19 Million USD	-30.36%
Tufton Oceanic Assets Limited	76.06 Million USD	-42.57%
Symphony International Holdings Limited	-102.23 Million USD	206.079%
Tetragon Financial Group Limited	141.1 Million USD	23.14%
Taylor Maritime Investments Limited	-53.48 Million USD	302.775%
TMT Investments PLC	6.37 Million USD	-1600.437%
Third Point Investors Limited	11.41 Million USD	-849.712%